Cargando…
Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial
BACKGROUND: We aimed to evaluate the effects of different therapeutic options to prevent the evolution of vaginal stenosis after pelvic radiotherapy in women with cervical cancer. METHODS: open-label randomized clinical trial of 195 women, stage I-IIIB, aged 18–75 years, using topical estrogen (66),...
Autores principales: | Martins, Jumara, Vaz, Ana Francisca, Grion, Regina Celia, Costa-Paiva, Lúcia, Baccaro, Luiz Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191143/ https://www.ncbi.nlm.nih.gov/pubmed/34112100 http://dx.doi.org/10.1186/s12885-021-08274-w |
Ejemplares similares
-
Correction to: Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial
por: Martins, Jumara, et al.
Publicado: (2021) -
Urologic trauma from vaginal dilation for congenital vaginal stenosis: A newly-described and challenging complication
por: Lue, Kathy, et al.
Publicado: (2019) -
Compliance and clinical efficacy of vaginal dilator after radiotherapy for cervical and endometrial malignancies
por: Tahseen, Rabia, et al.
Publicado: (2023) -
Consensus for vaginal stenosis prevention in patients submitted to pelvic radiotherapy
por: Matos, Sabrina Rosa de Lima, et al.
Publicado: (2019) -
Effects of topical estrogen therapy on the vaginal microcirculation in women with vulvovaginal atrophy
por: Diedrich, Chantal M., et al.
Publicado: (2019)